271 related articles for article (PubMed ID: 17470754)
1. Cognitive decline in Alzheimer disease: Impact of spirituality, religiosity, and QOL.
Kaufman Y; Anaki D; Binns M; Freedman M
Neurology; 2007 May; 68(18):1509-14. PubMed ID: 17470754
[TBL] [Abstract][Full Text] [Related]
2. Relationship between quality of life and cognitive decline in dementia.
Missotten P; Squelard G; Ylieff M; Di Notte D; Paquay L; De Lepeleire J; Buntinx F; Fontaine O
Dement Geriatr Cogn Disord; 2008; 25(6):564-72. PubMed ID: 18544978
[TBL] [Abstract][Full Text] [Related]
3. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
[TBL] [Abstract][Full Text] [Related]
4. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
Rascovsky K; Salmon DP; Lipton AM; Leverenz JB; DeCarli C; Jagust WJ; Clark CM; Mendez MF; Tang-Wai DF; Graff-Radford NR; Galasko D
Neurology; 2005 Aug; 65(3):397-403. PubMed ID: 16087904
[TBL] [Abstract][Full Text] [Related]
5. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
Kester MI; van der Vlies AE; Blankenstein MA; Pijnenburg YA; van Elk EJ; Scheltens P; van der Flier WM
Neurology; 2009 Oct; 73(17):1353-8. PubMed ID: 19858456
[TBL] [Abstract][Full Text] [Related]
6. The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease.
Holtzer R; Wegesin DJ; Albert SM; Marder K; Bell K; Albert M; Brandt J; Stern Y
Arch Neurol; 2003 Aug; 60(8):1137-42. PubMed ID: 12925372
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
Squitti R; Bressi F; Pasqualetti P; Bonomini C; Ghidoni R; Binetti G; Cassetta E; Moffa F; Ventriglia M; Vernieri F; Rossini PM
Neurology; 2009 Jan; 72(1):50-5. PubMed ID: 19122030
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: a two-year follow-up study.
Tatsumi H; Nakaaki S; Torii K; Shinagawa Y; Watanabe N; Murata Y; Sato J; Mimura M; Furukawa TA
Psychiatry Clin Neurosci; 2009 Jun; 63(3):374-84. PubMed ID: 19566770
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease.
Deschaintre Y; Richard F; Leys D; Pasquier F
Neurology; 2009 Sep; 73(9):674-80. PubMed ID: 19720973
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease.
Spalletta G; Bernardini S; Bellincampi L; Federici G; Trequattrini A; Ciappi F; Bria P; Caltagirone C; Bossù P
Am J Geriatr Psychiatry; 2007 Oct; 15(10):879-87. PubMed ID: 17911365
[TBL] [Abstract][Full Text] [Related]
11. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
[TBL] [Abstract][Full Text] [Related]
12. Symptoms of anxiety and depression in the course of cognitive decline.
Bierman EJ; Comijs HC; Jonker C; Beekman AT
Dement Geriatr Cogn Disord; 2007; 24(3):213-9. PubMed ID: 17690554
[TBL] [Abstract][Full Text] [Related]
13. Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type.
Bellew KM; Pigeon JG; Stang PE; Fleischman W; Gardner RM; Baker WW
Alzheimer Dis Assoc Disord; 2004; 18(4):208-13. PubMed ID: 15592132
[TBL] [Abstract][Full Text] [Related]
14. Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: the REAL longitudinal cohort study.
Lechowski L; Benoit M; Chassagne P; Vedel I; Tortrat D; Teillet L; Vellas B
Int J Geriatr Psychiatry; 2009 Apr; 24(4):341-6. PubMed ID: 18814198
[TBL] [Abstract][Full Text] [Related]
15. Cognitive decline and survival in Alzheimer's disease according to education level.
Bruandet A; Richard F; Bombois S; Maurage CA; Masse I; Amouyel P; Pasquier F
Dement Geriatr Cogn Disord; 2008; 25(1):74-80. PubMed ID: 18042993
[TBL] [Abstract][Full Text] [Related]
16. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study.
Luckhaus C; Grass-Kapanke B; Blaeser I; Ihl R; Supprian T; Winterer G; Zielasek J; Brinkmeyer J
Int J Geriatr Psychiatry; 2008 Nov; 23(11):1148-55. PubMed ID: 18537220
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in older Belgian people: comparison between people with dementia, mild cognitive impairment, and controls.
Missotten P; Squelard G; Ylieff M; Di Notte D; Paquay L; De Lepeleire J; Fontaine O
Int J Geriatr Psychiatry; 2008 Nov; 23(11):1103-9. PubMed ID: 18213606
[TBL] [Abstract][Full Text] [Related]
18. VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study.
Kinkingnéhun S; Sarazin M; Lehéricy S; Guichart-Gomez E; Hergueta T; Dubois B
Neurology; 2008 Jun; 70(23):2201-11. PubMed ID: 18448872
[TBL] [Abstract][Full Text] [Related]
19. Cognitive decline in early Parkinson's disease.
Kandiah N; Narasimhalu K; Lau PN; Seah SH; Au WL; Tan LC
Mov Disord; 2009 Mar; 24(4):605-8. PubMed ID: 19191342
[TBL] [Abstract][Full Text] [Related]
20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
